This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| W.\,W. von Andrian | |
|---|---|
| Name | W. W. von Andrian |
| Birth date | 1950s |
| Nationality | German-born |
| Fields | Immunology, Cell Biology |
| Institutions | Harvard Medical School, Brigham and Women's Hospital, Max Planck Institute |
| Alma mater | University of Hamburg, University of Freiburg |
| Known for | Imaging of leukocyte trafficking, dendritic cell migration, chemokine-mediated homing |
W.\,W. von Andrian
W. W. von Andrian is a German-born immunologist and cell biologist known for pioneering intravital microscopy studies of leukocyte trafficking and dendritic cell behavior, influencing research at institutions such as Harvard Medical School, Brigham and Women's Hospital, Max Planck Society, and the European Molecular Biology Laboratory. His work links mechanistic insights about chemokines and selectins to functional outcomes relevant to HIV, malaria, tuberculosis, and transplantation research, shaping thinking in laboratories affiliated with National Institutes of Health, Rockefeller University, and Stanford University.
Von Andrian grew up in postwar Germany and completed medical and doctoral training at the University of Hamburg and the University of Freiburg, receiving mentorship grounded in traditions associated with the Max Planck Institute for Immunobiology and Epigenetics and clinical exposure at Charité – Universitätsmedizin Berlin. During graduate work he interacted with scientists trained in the laboratories of Paul Ehrlich-linked institutes and attended conferences organized by the European Molecular Biology Organization, which influenced his move toward cellular imaging and translational immunology. Early collaborations connected him with investigators from the Imperial College London and the Pasteur Institute, setting a foundation for international research appointments.
Von Andrian established a research program that integrated intravital two-photon microscopy, flow cytometry techniques pioneered at Cold Spring Harbor Laboratory, and molecular tools developed in consort with groups at Massachusetts Institute of Technology and University of Oxford. His laboratory at Harvard Medical School and Brigham and Women's Hospital focused on leukocyte-endothelial interactions involving selectins, integrins, and chemokine receptors such as CCR7 and CXCR5, collaborating with structural biology teams at the European Molecular Biology Laboratory and Max Planck Institute for Multidisciplinary Sciences. He pursued translational projects in partnership with clinicians at Beth Israel Deaconess Medical Center and investigators affiliated with the National Institute of Allergy and Infectious Diseases, while mentoring postdocs who later joined faculty at Yale University, University of California, San Francisco, and University of Toronto.
Von Andrian produced seminal observations on the multistep paradigm of leukocyte extravasation, clarifying roles for L-selectin, E-selectin, and P-selectin in rolling, arrest, and transmigration within inflamed venules studied in real time. He used intravital microscopy to visualize dendritic cell migration from peripheral tissues to draining lymph nodes, demonstrating how CCR7-dependent chemotaxis and interactions with stromal networks like fibroblastic reticular cells regulate antigen presentation to T cells in lymphoid microenvironments influenced by signals from interleukin-2 and interleukin-7. His lab revealed mechanisms by which sphingosine-1-phosphate gradients and S1PR1 signaling mediate lymphocyte egress from lymph nodes, findings that interacted conceptually with clinical developments around modulators such as fingolimod used in multiple sclerosis. Von Andrian dissected neutrophil swarming behaviors and neutrophil extracellular trap dynamics relevant to sepsis and deep vein thrombosis, and he integrated chemokine biochemistry with live imaging to show how haptotactic gradients of CCL21 and CXCL13 coordinate B cell and T cell positioning in germinal centers, complementing structural studies from labs at Rockefeller University and Cold Spring Harbor Laboratory.
His scientific achievements have been recognized by election to national and international bodies and by awards from organizations including the American Association of Immunologists, the European Federation of Immunological Societies, and societies linked to the Max Planck Society. He has been invited to deliver named lectures at venues such as the Gairdner Foundation symposium, the Keystone Symposia, and the Feldberg Foundation meetings, and has held visiting professorships at University College London and the Weizmann Institute of Science. Grant support for his work has come from agencies such as the National Institutes of Health, the European Research Council, and national funding bodies associated with the German Research Foundation.
Outside the laboratory, von Andrian has been active in advising translational initiatives bridging academia and biotechnology firms in the Boston and Berlin regions, and in shaping graduate education frameworks at Harvard Medical School and European doctoral programs tied to the EMBO network. His trainees populate departments at institutions such as Duke University, Johns Hopkins University, and the University of Cambridge, extending influence through research on immunotherapies, vaccine design, and inflammation biology. The methodological standards he set for live imaging, combined with conceptual models for leukocyte navigation and antigen presentation, continue to inform work at centers including Institut Pasteur, Children's Hospital Boston, and the Scripps Research Institute, securing his legacy in contemporary immunology.
Category:Immunologists Category:Cell biologists Category:Harvard Medical School faculty